Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Pharmacol ; 779: 46-52, 2016 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-26948318

RESUMO

Salidroside is known for its pharmacological properties and in particular its antioxidation effects. In recent years, it has been recognized that salidroside plays an important role in treating diabetes. Accumulated evidence suggests that microRNAs may be involved in diabetic lipid disorders. We investigated how salidroside regulates lipid metabolism through miR-370 in vivo and in vitro. After 4 weeks of a high-fat diet, and intraperitoneal injection of streptozotocin (100mg/kg), type 2 diabetes was induced in male C56BL/6J mice. After 4 weeks, mice with fasting blood glucose levels above 7.8mmol/l were divided into five groups: those with diabetes mellitus, and those treated with 40mg/kg, 80mg/kg, and 160mg/kg salidroside, and metformin (480mg/kg), for a further 4 weeks. The hypoglycemic effects of salidroside were consistently demonstrated when measuring fasting blood glucose levels, observing insulin-sensitizing effects, and testing oral glucose tolerance. In addition to this, the expressions of miR-370, and related lipid protein expression in primary hepatocytes, were examined in primary type 2 diabetic mice. The present study has shown that the expression levels of miR-370, SREBP-1 and FAS-1 were significantly elevated in the liver of type 2 diabetic mice. In contrast, the elevated expression levels were reversed by salidroside. The addition of salidroside attenuated the effect of miR-370, and reduced the expression of these lipid metabolism proteins in primary hepatocytes. These findings demonstrate that salidroside can directly decrease the expression of miR-370 in type 2 diabetic mice, and particularly in primary hepatocytes, affecting lipid metabolism in the liver.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Regulação para Baixo/efeitos dos fármacos , Glucosídeos/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , MicroRNAs/genética , Fenóis/farmacologia , Animais , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/genética , Glucosídeos/uso terapêutico , Insulina/sangue , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fenóis/uso terapêutico
2.
Huan Jing Ke Xue ; 34(2): 476-83, 2013 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-23668112

RESUMO

The concentrations of typical heavy metals including Cu, Hg, Pb, Zn, Mn, Cd, Cr and As in the surface sediment and suspended particulate matter (SPM) in Jinghai Bay, Rongcheng city were tested. The degree of heavy metal pollution in the surface sediment was assessed according to the national standard of marine sediment quality. The potential ecological risk (PER) of heavy metals to marine ecosystem in Jinghai Bay was assessed using PER coefficient and risk index. The results showed that the levels of heavy metals and PER in the surface sediments were low enough to meet the requirement of the first class of the sediment quality standards except the levels of Cu and Zn in the sampling site S2 and Cd in S3, S4, S5 and S6 which met the requirements of the second class of the sediment quality standards. The PER coefficients of heavy metals increased following the sequence of Zn < Cr < Pb < Cu < As

Assuntos
Monitoramento Ambiental/métodos , Marcação por Isótopo/métodos , Chumbo/análise , Metais Pesados/análise , Poluentes Químicos da Água/análise , Baías , China , Sedimentos Geológicos/química , Radioisótopos de Chumbo/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...